Patients report that GLP-1 drugs like Ozempic and Mounjaro reduce “food noise,” the constant mental chatter about eating.

A trade group representing compounding pharmacies has filed a lawsuit against the Food and Drug Administration (FDA) for ...

You've probably seen the ads for GLP-1 drugs. It's a hormone that helps people lose weight, but the results are not ...

Jon Stewart railed against sweeping cuts by the Department of Government Efficiency (DOGE) — and suffered one of his own in ...

Eli Lilly said on Tuesday it cut the price for vials of its weight-loss drug Zepbound by $50 or more and expanded the range ...

Coverage complications are not unusual in the U.S. health care system. But the challenge is magnified for these obesity ...

Hims & Hers (HIMS) made a killing last year selling an off-brand version of Ozempic, but with the drug’s shortage now over, ...

A rift is emerging between the east and west of the EU over what to do with Russia’s seized central bank reserves.

The Supreme Court has stayed in the interim a Kerala High Court order directing the Centre to provide an additional Rs 18 ...

Hims & Hers stock tumbled after the company confirmed it would stop selling some compounded weight-loss drugs.

A new study found that some medications could have the unintended benefit of reducing dementia risk, while others could increase the risk. A doctor comments on the findings.

Legislators may launch a study of how weight loss drugs might reduce costs in the Iowa Medicaid program. Jeffrey Boeyink is a ...